MPC-06-ID

  Fasten your seatbelts! You’d be hard pressed to find a biotech company anywhere in the world with a more exciting calendar than Mesoblast in the next two months.  Front and center is the lead product candidate Remestemcel-L, or Ryoncil.  Not later than September 30th, the FDA will decide whether Read more…